Kames Capital Plc Upped Medidata Solutions (MDSO) Position; Cantel Medical (CMD) Shorts Decreased By 3.63%

Medidata Solutions, Inc. (NASDAQ:MDSO) Logo

Kames Capital Plc increased Medidata Solutions Inc. (MDSO) stake by 54.59% reported in 2017Q4 SEC filing. Kames Capital Plc acquired 9,012 shares as Medidata Solutions Inc. (MDSO)’s stock declined 3.23%. The Kames Capital Plc holds 25,521 shares with $1.62 million value, up from 16,509 last quarter. Medidata Solutions Inc. now has $4.29B valuation. The stock decreased 0.86% or $0.63 during the last trading session, reaching $72.51. About 505,054 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 13.38% since April 24, 2017 and is uptrending. It has outperformed by 1.83% the S&P500.

Cantel Medical Corp (NYSE:CMD) had a decrease of 3.63% in short interest. CMD’s SI was 552,600 shares in April as released by FINRA. Its down 3.63% from 573,400 shares previously. With 683,400 avg volume, 1 days are for Cantel Medical Corp (NYSE:CMD)’s short sellers to cover CMD’s short positions. The SI to Cantel Medical Corp’s float is 1.53%. The stock decreased 0.12% or $0.14 during the last trading session, reaching $115.7. About 117,218 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 41.41% since April 24, 2017 and is uptrending. It has outperformed by 29.86% the S&P500.

Kames Capital Plc decreased Bank Of America Corporation (NYSE:BAC) stake by 129,500 shares to 2.18M valued at $64.37 million in 2017Q4. It also reduced Cohen Steers Inc. (NYSE:CNS) stake by 7,949 shares and now owns 39,292 shares. Nvidia Corporation (NASDAQ:NVDA) was reduced too.

Since December 19, 2017, it had 0 insider buys, and 9 insider sales for $4.86 million activity. Shares for $132,920 were sold by Bergmann Rouven on Friday, January 19. Sherif Tarek sold $1.89 million worth of stock. The insider de Vries Glen Michael sold 26,836 shares worth $1.88M.

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Medidata Solutions Inc. has $92.0 highest and $35 lowest target. $73.93’s average target is 1.96% above currents $72.51 stock price. Medidata Solutions Inc. had 44 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Monday, August 21 with “Hold”. Topeka Capital Markets upgraded it to “Buy” rating and $50 target in Wednesday, October 28 report. Topeka Capital Markets maintained the stock with “Buy” rating in Thursday, February 11 report. The rating was downgraded by Wells Fargo to “Market Perform” on Thursday, July 21. Wells Fargo upgraded it to “Buy” rating and $80.0 target in Friday, December 1 report. The firm has “Hold” rating given on Friday, September 25 by Topeka Capital Markets. As per Monday, October 23, the company rating was maintained by Needham. KeyBanc Capital Markets initiated Medidata Solutions, Inc. (NASDAQ:MDSO) on Wednesday, September 9 with “Overweight” rating. Jefferies maintained it with “Hold” rating and $7800 target in Tuesday, July 18 report. Jefferies maintained the stock with “Hold” rating in Thursday, February 8 report.

Investors sentiment increased to 1.71 in Q4 2017. Its up 0.48, from 1.23 in 2017Q3. It improved, as 22 investors sold MDSO shares while 61 reduced holdings. 49 funds opened positions while 93 raised stakes. 61.06 million shares or 2.97% more from 59.30 million shares in 2017Q3 were reported. Strs Ohio invested in 0.04% or 163,797 shares. Us Fincl Bank De holds 0% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 8,698 shares. Eagle Asset Mngmt stated it has 0.31% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Eulav Asset Management holds 0.29% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 96,000 shares. Alliancebernstein Limited Partnership accumulated 0% or 88,547 shares. Hutchin Hill Limited Partnership holds 0.1% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 5,600 shares. 80 are held by Stratos Wealth Ltd. Fortaleza Asset Mgmt Inc accumulated 1,985 shares. The Connecticut-based Axiom Int Investors Llc De has invested 0.09% in Medidata Solutions, Inc. (NASDAQ:MDSO). Royal Retail Bank Of Canada has 685,772 shares for 0.02% of their portfolio. Finance Architects accumulated 62 shares or 0% of the stock. Champlain Inv Ptnrs Ltd Com reported 1.33% stake. Trexquant Investment LP holds 0.11% in Medidata Solutions, Inc. (NASDAQ:MDSO) or 15,704 shares. Wellington Mgmt Grp Llp invested in 280,257 shares. Invesco Limited accumulated 794,934 shares.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $4.83 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 53.66 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Cantel Medical Corp. (NYSE:CMD) Institutional Positions Chart